Skip to content

    ADD & ADHD Health Center

    Font Size
    A
    A
    A

    Experts Urge Stern ADHD Drug Warnings

    Surprise Vote Follows Preliminary Study Suggesting Risks
    By
    WebMD Health News

    Feb. 9, 2006 -- In a surprise move, an advisory panel urged the FDA to place strong warnings on all stimulant drugs used to treat attention deficit hyperactivity disorder (ADHD) because of a potential risk of heart attacks, strokes, and sudden death.

    The experts voted unanimously, with one abstention, to recommend that FDA include "medication guides" with all stimulant ADHD drugs -- Adderall, Concerta, and Ritalin -- warning patients about the potential heart risks.

    The panel also voted 8 to 7, with one abstention, to urge the FDA to place strong "black box" warnings on all of the drugs' labels and advertisements. The warning should alert doctors and patients the drugs increase heart rate and blood pressure, and that researchers are unsure about the real-world consequences of those changes, some panelists said.

    As with all recommended warnings, patients and parents should first consult with a doctor before making any treatment decisions.

    Unusual Move

    Committees sometimes recommend such warnings for drugs believed to carry dangerous side effects. But Thursday's move was highly unusual because the panel was convened to advise the FDA on how to design studies looking at potential health risks with ADHD stimulant drugs.

    Instead, several experts expressed strong concerns that stimulant drugs like Adderall and Ritalin were being overprescribed -- particularly to adults -- and that the public and doctors were largely unaware of potential risks. A number moved that the panel step outside its agenda and vote on stronger warnings for the drugs.

    "I think the only way we're going to get the attention of the medical community and the pharmacy community ... is through the black box warning," said Henri R. Mannasse Jr., PhD, CEO of the American System of Health System Pharmacists and a member of the panel.

    The FDA does not have to follow the committee's recommendation. Officials appeared to be caught off-guard by the committee's action.

    1 | 2 | 3 | 4

    Today on WebMD

    Post it notes
    Symptoms and treatments.
    Close up of eye
    What's zapping your focus?
     
    man driving car
    How to manage your impulses.
    contemplating woman
    Learn to stop procrastinating.
     
    concentration killers
    SLIDESHOW
    Woman taking a vitamin or supplement
    Article
     
    ADHD and Substance Abuse
    Article
    Reduce Side Effects ADHD Medications
    Article
     

    woman with adhd doing college homework
    Article
    smiling man
    Article
     
    ADHD in Marriage and Romantic Relationships
    Article
    Adult man lying awake in bed
    Article